Current team members

Gino Kwon, Ph.D.
Postdoctoral Fellow

Yanjiang Luo, M.D.
Doctoral Student

Camila Cancino
Ph.D. Student

Mariia Saliutina
Ph.D. Student 

Luis Velasco
Ph.D. Student 

Agata Konopka
M.D. Student 

Kim Susan Juhran
M.D. Student 

Anaïs Aklé
Master Student 

Anna Mikołajczyk
Project coordinator

Zhenjie Yin, M.D.
Doctoral Student

Gino Kwon is from South Korea and joined the team in June 2024. He took a doctorate course at the Humboldt-Universität zu Berlin and DRFZ on autoimmune diseases and immune cells and a master's course at the Yonsei University Seoul and Severance Hospital on cancer genomics and bioinformatics. Before that, he worked in the financial, applied statistics, and data mining industries. He analyzes Omics data on multiple diseases and experimental samples.

Yanjiang Luo is from China. He studied medicine at the JiangNan University and Southeast University in China and graduated in July 2020. Yanjiang joined the Hegazy Lab in December 2020 to perform his doctoral studies at the Charité-University Medicine Berlin. In his doctoral thesis Yanjiang is analysing the role of Oncostatin M in bacterial and viral infections. 

Camila Cancino is from Chile. Camila did her bachelor's degree in Biochemistry at the University of Santiago. Camila worked as a research assistant and flow cytometry manager at Merken Biotech SPA, Chile, before relocating to Germany and starting her Ph.D. in May 2021. In her Ph.D. thesis, she is studying the impact of intestinal microbiota on CD4 T cell repertoire and how intestinal dysbiosis influences the memory CD4 T cell compartment. 

Mariia Saliutina is from the Russian Federation. She completed her undergraduate studies in the Molecular Biology Department at Lomonosov Moscow State University (MSU) and subsequently obtained her master’s degree in Molecular Biology from the same university in 2020. Prior to joining the Hegazy lab in August 2023, Mariia served as an analyst at the Center of Strategic Planning of the FMBA of Russia. Her doctoral research is centered on bioinformatics data analysis, with a particular emphasis on various aspects of IBD pathogenesis.

Luis Velasco is a biology grad from Universidad de Leon, Spain, later pursued advanced therapies and biological innovation in Madrid. Following an internship in stem cells, he delved into immunology at Hegazy Lab. Luis focuses on unraveling stroma and immune system dynamics in inflammation and fibrosis development in the gut, with a particular interest in investigating the OSM/OSMR axis in stroma-immune interaction. His dedication shines through in advancing our understanding of these complex processes.

Agata Konopka is from Poland. She studies medicine at Charité – Universitätsmedizin Berlin and is currently in her 7th semester. Agata joined the Hegazy Lab in spring 2023. In her doctoral thesis she is focusing on the role of Oncostatin M in acute pulmonary inflammation.

Kim Susan Juhran is a german medical student at Charité-University Medicine-Berlin. After finishing the 7th Semester she took a research sabbatical and joined the group in September 2023. She will focus on the recruitment and characterisation of distinct IBD patients receiving various biological samples.

Anaïs Aklé is from Germany and obtained her Bachelor of Science degree in Biology from the Freie Universität Berlin. She is currently enrolled in the Biochemistry and Molecular Biology Master's program at the University of Potsdam. In her Master’s thesis project she investigates the impact of Oncostatin M on gut-resident memory T cells.

Anna Mikołajczyk is from Poland. She obtained her Diploma degree in Biochemistry at the Freie Universität Berlin. Anna joined Hegazy Lab in autumn 2023 as a Project Coordinator.

Zhenjie Yin is from China. He holds a Bachelor of Medicine from Zunyi Medical University and a Master of Surgery from Fujian Medical University. In January 2024, Zhenjie joined the Hegazy Lab to pursue his doctorate at Charité-University Medicine Berlin. He studies the host-microbe dialogue in inflammatory bowel disease, focusing on non-immune cells and MHC-II molecules.